Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Justin Roberts

Orthopaedic Surgery Phoenix, AZ Medical Doctor

NPI 1396001202 CMS profile 3075728

2222 E Highland Ave Ste 300, Phoenix, AZ 85016

Open in the dashboard

General payments

$8,936

71 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justin Roberts of Phoenix, AZ is reported in the CMS Open Payments database as having received $8,936 across 71 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $748 9
2024 General $488 9
2023 General $694 10
2022 General $1,370 8
2021 General $456 11
2020 General $3,716 18
2019 General $1,464 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justin Roberts
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Justin Roberts were reported at $748. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Justin Roberts Orthopaedic Surgery median Middle half National median
2019 $1,464 $644 $140–$2,844 $163
2020 $3,716 $312 $75–$1,860 $114
2021 $456 $520 $117–$2,495 $132
2022 $1,370 $598 $128–$2,731 $149
2023 $694 $461 $128–$2,264 $160
2024 $488 $497 $134–$2,475 $164
2025 $748 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Goode Surgical Inc $3,469 6 payments
  2. ImpactOrtho, Inc. $2,010 3 payments
  3. Stryker Corporation $1,299 13 payments
  4. DePuy Synthes Sales Inc. $854 10 payments
  5. Smith+Nephew, Inc. $427 20 payments
  6. Olympus America Inc. $264 2 payments
  7. Boston Scientific Corporation $142 3 payments
  8. Ortho Development Corporation $126 2 payments
  9. Paragon 28, Inc. $96 1 payment
  10. Zimmer Biomet Holdings, Inc. $78 1 payment
  11. Other $170 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $5,403 4 payments
  2. Food and Beverage $3,533 67 payments
Products named General payments · program years 2019–2025
  1. ATTUNE $404 5 payments
  2. INBONE $345 3 payments
  3. MAKO $326 2 payments
  4. Olympus Energy $264 2 payments
  5. VARIAX $197 2 payments
  6. INFINITY $170 1 payment
  7. VISIONAIRE $140 4 payments
  8. AUGMENT INJECTABLE $136 2 payments
  9. CYSTO-NEPHRO VIDEOSCOPE $132 1 payment
  10. Olympus Energy $132 1 payment
  11. Other $2,193 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

131

Median for Orthopedic Surgery: 203

Drug cost

$1,381

Median for Orthopedic Surgery: $1,433

Branded share of claims

22.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 23 $618
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 30 $378
Methylprednisolone Generic 29 $221
Tramadol Hcl Generic 22 $72
Meloxicam Generic 12 $70
Amoxicillin Generic 15 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$228,385

Of which drugs: $44,936

Medicare patients

466

Average age 74

Services billed

4,208

288 women, 178 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Ischemic heart disease 27%
Diabetes 22%
Chronic kidney disease 21%
Osteoporosis 20%
Depression 19%
Atrial fibrillation 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose J7327 Office 29 38 $20,648
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 27 165 $16,291
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose J7323 Office 19 69 $6,529
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 135 1,852 $1,286

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

71 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record